BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1929259)

  • 1. Metabolic disposition and pharmacokinetics of the antiviral agent 6-methoxypurine arabinoside in rats and monkeys.
    Burnette TC; Koszalka GW; Krenitsky TA; De Miranda P
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1165-73. PubMed ID: 1929259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and pharmacokinetics of the anti-varicella-zoster virus agent 6-dimethylaminopurine arabinoside.
    Lambe CU; Resetar A; Spector T; Koszalka GW; Nelson DJ
    Antimicrob Agents Chemother; 1992 Feb; 36(2):353-60. PubMed ID: 1318679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virus.
    de Miranda P; Burnette TC; Biron KK; Miller RL; Averett DR; Krenitsky TA
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2121-4. PubMed ID: 1662024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective anabolism of 6-methoxypurine arabinoside in varicella-zoster virus-infected cells.
    Biron KK; de Miranda P; Burnette TC; Krenitsky TA
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2116-20. PubMed ID: 1722079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.
    Averett DR; Koszalka GW; Fyfe JA; Roberts GB; Purifoy DJ; Krenitsky TA
    Antimicrob Agents Chemother; 1991 May; 35(5):851-7. PubMed ID: 1649571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and metabolism of [14C]viramidine in rats and cynomolgus monkeys.
    Lin CC; Luu K; Lourenco D; Yeh LT
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2458-63. PubMed ID: 12878505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo disposition and metabolism of 3'-deoxy-2',3'-didehydrothymidine.
    Cretton EM; Zhou Z; Kidd LB; McClure HM; Kaul S; Hitchcock MJ; Sommadossi JP
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1816-25. PubMed ID: 8239589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies.
    Lambe CU; Averett DR; Paff MT; Reardon JE; Wilson JG; Krenitsky TA
    Cancer Res; 1995 Aug; 55(15):3352-6. PubMed ID: 7614470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
    Radulovic LL; Türck D; von Hodenberg A; Vollmer KO; McNally WP; DeHart PD; Hanson BJ; Bockbrader HN; Chang T
    Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration.
    Tang-Liu DD; Richman JB; Lin P; Selim S
    Biopharm Drug Dispos; 1993 May; 14(4):313-24. PubMed ID: 8499582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced brain delivery of an anti-HIV nucleoside 2'-F-ara-ddI by xanthine oxidase mediated biotransformation.
    Shanmuganathan K; Koudriakova T; Nampalli S; Du J; Gallo JM; Schinazi RF; Chu CK
    J Med Chem; 1994 Mar; 37(6):821-7. PubMed ID: 8145233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal toxicity of 6-methoxypurine arabinoside (ara-M). A new selective and potent inhibitor of varicella-zoster virus.
    Karaçorlu S; Peyman GA; Karaçorlu M; Dunlap W; Soike KF
    Retina; 1992; 12(3):261-4. PubMed ID: 1329170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxic effects of the anti-varicella zoster virus agent 2'-valeryl-6-methoxypurine arabinoside in monkeys and rats dosed orally for 90 days.
    Szczech GM; Tucker WE
    Fundam Appl Toxicol; 1992 Feb; 18(2):314-20. PubMed ID: 1318240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
    Nakamura A; Hirota T; Sugihara K; Morino A
    Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virus.
    Frick LW; Lambe CU; St John L; Taylor LC; Nelson DJ
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2722-9. PubMed ID: 7695253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor alpha agonist in preclinical species and human.
    Frederick KS; Maurer TS; Kalgutkar AS; Royer LJ; Francone OL; Winter SM; Terra SG; Chen D; Gao X
    Xenobiotica; 2009 Oct; 39(10):766-81. PubMed ID: 19622022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of [14C]aztreonam in rats, dogs, and monkeys.
    Kripalani KJ; Singhvi SM; Weinstein SH; Everett DW; Bathala MS; Dean AV; Ita CE; Lawrence L; Meeker FS; Shaw JM
    Antimicrob Agents Chemother; 1984 Aug; 26(2):119-26. PubMed ID: 6541449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition and metabolism of [14C]brasofensine in rats, monkeys, and humans.
    Zhu M; Whigan DB; Chang SY; Dockens RC
    Drug Metab Dispos; 2008 Jan; 36(1):24-35. PubMed ID: 17908924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.